📣 VC round data is live. Check it out!
- Public Comps
- Dynavox Group
Dynavox Group Valuation Multiples
Discover Dynavox Group's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like LifeTech Scientific, Xvivo Perfusion, QuidelOrtho, Anteris Technologies US and more.
Dynavox Group Overview
About Dynavox Group
Dynavox Group AB is engaged in assistive technology for communication. The company's Augmentative and Alternative Communication (AAC) solutions enable people with disabilities such as cerebral palsy, ALS, and spinal cord injury to communicate with a voice of their own, develop literacy skills, and live more independently. The company is a comprehensive SaaS provider with local roots. The company operates in Europe, North America, and Other countries, with the majority of revenue from North America.
Founded
1983
HQ

Employees
874
Website
Financials (LTM)
EV
$1B
Valuation Multiples
Start free trialDynavox Group Financials
Dynavox Group reported last 12-month revenue of $286M and EBITDA of $67M.
In the same LTM period, Dynavox Group generated $196M in gross profit, $67M in EBITDA, and $25M in net income.
Revenue (LTM)
Dynavox Group P&L
In the most recent fiscal year, Dynavox Group reported revenue of $273M and EBITDA of $63M.
Dynavox Group is profitable as of last fiscal year, with gross margin of 66%, EBITDA margin of 23%, and net margin of 7%.
Financial data powered by Morningstar, Inc.
Dynavox Group Stock Performance
Dynavox Group has current market cap of $924M, and enterprise value of $1B.
Market Cap Evolution
Dynavox Group's stock price is $8.76.
Dynavox Group share price decreased by 1.4% in the last 30 days, and by 27.4% in the last year.
Dynavox Group has an EPS (earnings per share) of $0.17.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $924M | -0.5% | -1.4% | -8.4% | -27.4% | $0.17 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDynavox Group Valuation Multiples
Dynavox Group trades at 3.6x EV/Revenue multiple, and 15.1x EV/EBITDA.
EV / Revenue (LTM)
Dynavox Group Financial Valuation Multiples
As of June 4, 2026, Dynavox Group has market cap of $924M and EV of $1B.
Dynavox Group has a P/E ratio of 36.9x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Dynavox Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Dynavox Group Margins & Growth Rates
Dynavox Group grew revenue by 11% and EBITDA by 17% in the last fiscal year.
In the most recent fiscal year, Dynavox Group reported gross margin of 66%, EBITDA margin of 23%, and net margin of 7%.
Dynavox Group Margins
Dynavox Group Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Dynavox Group Operational KPIs
Dynavox Group's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Dynavox Group's Rule of 40 is 39% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Dynavox Group's Rule of X is 61% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Dynavox Group Competitors
Dynavox Group competitors include LifeTech Scientific, Xvivo Perfusion, QuidelOrtho, Anteris Technologies US, Kuros Biosciences, SEEGENE, Barco, PHC Holdings, Artivion and ChemoMetec.
Most Dynavox Group public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 3.7x | - | 17.1x | - | |||
| 10.0x | 9.3x | 50.4x | 43.9x | |||
| 1.3x | 1.3x | 6.1x | 6.0x | |||
| 327.4x | 141.9x | (7.0x) | (6.3x) | |||
| 5.0x | 5.4x | 57.6x | 46.4x | |||
| 1.9x | 1.9x | 7.4x | 7.7x | |||
| 0.6x | 0.6x | 4.3x | 4.4x | |||
| 0.9x | 0.9x | 6.4x | 6.3x | |||
This data is available for Pro users. Sign up to see all Dynavox Group competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Dynavox Group
Dynavox Group has acquired 3 companies to date.
Last acquisition by Dynavox Group was on December 23rd 2025. Dynavox Group acquired SR Labs for $5M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Dynavox Group
| Description | SR Labs is an Italian eye-tracking technology specialist developing multi-modal systems for automotive, research, and human-machine interaction applications. | RehaMedia is a Germany-based distributor of assistive technologies for people with physical and cognitive disabilities, headquartered in Hannover. The company supplies cognition aids like MEMOplanner, eye-gaze communication systems, environmental controls, computer adaptations, and therapy tools from brands such as Tobii and Pretorian. RehaMedia provides nationwide consultation, sales, training, and maintenance services, partnering with clinics and schools across North Rhine-Westphalia and beyond. | Cenomy is a Paris-based developer of electronic communication aids for individuals with motor and cognitive disabilities. The company produces eye-tracking devices, speech synthesizers, and adaptive interfaces integrated with tablets for daily autonomy. Its products support French healthcare systems and schools, with deployments in over 500 facilities. Founded in 2012, Cenomy collaborates with hospitals like AP-HP for customized solutions. |
| HQ Country | |||
| HQ City | - | Duisburg | Saint-Apollinaire |
| Deal Date | 23 Dec 2025 | 11 Jul 2025 | 8 Apr 2025 |
| Valuation | $5M | $6M | $5M |
| EV/Revenue | |||
| EV/EBITDA | |||
This data is available for Pro users. Sign up to see all Dynavox Group acquisitions and their M&A valuation multiples. Start Free Trial | |||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Dynavox Group
| When was Dynavox Group founded? | Dynavox Group was founded in 1983. |
| Where is Dynavox Group headquartered? | Dynavox Group is headquartered in Sweden. |
| How many employees does Dynavox Group have? | As of today, Dynavox Group has over 874 employees. |
| Who is the CEO of Dynavox Group? | Dynavox Group's CEO is Fredrik Ruben. |
| Is Dynavox Group publicly listed? | Yes, Dynavox Group is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Dynavox Group? | Dynavox Group trades under DYVOX ticker. |
| When did Dynavox Group go public? | Dynavox Group went public in 2021. |
| Who are competitors of Dynavox Group? | Dynavox Group main competitors include LifeTech Scientific, Xvivo Perfusion, QuidelOrtho, Anteris Technologies US, Kuros Biosciences, SEEGENE, Barco, PHC Holdings, Artivion, ChemoMetec. |
| What is the current market cap of Dynavox Group? | Dynavox Group's current market cap is $924M. |
| What is the current revenue of Dynavox Group? | Dynavox Group's last 12 months revenue is $286M. |
| What is the current revenue growth of Dynavox Group? | Dynavox Group revenue growth (NTM/LTM) is 14%. |
| What is the current EV/Revenue multiple of Dynavox Group? | Current revenue multiple of Dynavox Group is 3.6x. |
| What is the current EBITDA of Dynavox Group? | Dynavox Group's last 12 months EBITDA is $67M. |
| What is Dynavox Group's EBITDA margin? | Dynavox Group's last 12 months EBITDA margin is 24%. |
| What is the current EV/EBITDA multiple of Dynavox Group? | Current EBITDA multiple of Dynavox Group is 15.1x. |
| What is the current FCF of Dynavox Group? | Dynavox Group's last 12 months FCF is $7M. |
| What is Dynavox Group's FCF margin? | Dynavox Group's last 12 months FCF margin is 2%. |
| What is the current EV/FCF multiple of Dynavox Group? | Current FCF multiple of Dynavox Group is 147.3x. |
| How many companies Dynavox Group has acquired to date? | As of June 2026, Dynavox Group has acquired 3 companies. |
| What was the largest acquisition by Dynavox Group? | $6M acquisition of RehaMedia on 11th July 2025 was the largest M&A Dynavox Group has done to date. |
| What companies Dynavox Group acquired? | Dynavox Group acquired RehaMedia, SR Labs, and Cenomy. |
| In how many companies Dynavox Group has invested to date? | Dynavox Group hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Dynavox Group
Lists including Dynavox Group
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.


